AMIFAMPRIDINE SERB 10 mg, tablet 100 tablets
Active ingredients: Amifampridine, Amifampridine phosphate
Commercialized according to BDPMDispensing in France: Prescription only
Tablet100 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- AMIFAMPRIDINE SERB 10 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- 100 plaquette(s) aluminium PVC-Aluminium PVDC de 1 comprimé (dose unitaire)
- Marketing authorisation holder
- SERB (BELGIQUE)
- Reimbursement according to BDPM
- 100 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 4 Oct 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69785998CIP73025244CIP133400930252444Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PHOSPHATE D'AMIFAMPRIDINEcomprimé | — | SA |
| AMIFAMPRIDINEcomprimé | 10 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.